Log in
Enquire now

List of Technovax, Inc. patents

List of Technovax, Inc. patents
List of PixelOptics patents
List of Celeno patents
List of New Mexico Tech patents
List of funding rounds for Avvay, Inc.
List of funding rounds for Lion Semiconductor
Patents where
Current Assignee
Name
is
Technovax, Inc.Technovax, Inc.
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 11389522 Flavivirus and alpha virus virus-like particles (VLPS)

Patent 11389522 was granted and assigned to Technovax, Inc. on July, 2022 by the United States Patent and Trademark Office.

Technovax, Inc.
Technovax, Inc.
Technovax, Inc.
Technovax, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
11389522
July 19, 2022
‌
US Patent 11529410 Universal virus-like particle (VLP) influenza vaccines

Patent 11529410 was granted and assigned to Technovax, Inc. on December, 2022 by the United States Patent and Trademark Office.

Technovax, Inc.
Technovax, Inc.
Technovax, Inc.
Technovax, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
11529410
December 20, 2022
‌
US Patent 11324816 Human respiratory syncytial virus (HRSV) virus-like particles (VLPS) based vaccine

Technovax, Inc.
Technovax, Inc.
Technovax, Inc.
Technovax, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
11324816
May 10, 2022
‌
US Patent 9387241 Influenza virus-like particle (VLP) compositions

Patent 9387241 was granted and assigned to Technovax, Inc. on July, 2016 by the United States Patent and Trademark Office.

Technovax, Inc.
Technovax, Inc.
Technovax, Inc.
Technovax, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
9387241
July 12, 2016
‌
US Patent 9352031 Universal virus-like particle (VLP) influenza vaccines

Patent 9352031 was granted and assigned to Technovax, Inc. on May, 2016 by the United States Patent and Trademark Office.

Technovax, Inc.
Technovax, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
9352031
May 31, 2016
‌
US Patent 10080796 Universal virus-like particle (VLP) influenza vaccines

Patent 10080796 was granted and assigned to Technovax, Inc. on September, 2018 by the United States Patent and Trademark Office.

Technovax, Inc.
Technovax, Inc.
Technovax, Inc.
Technovax, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
10080796
September 25, 2018
‌
US Patent 10695418 Universal virus-like particle (VLP) influenza vaccines

Technovax, Inc.
Technovax, Inc.
Technovax, Inc.
Technovax, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
10695418
June 30, 2020
‌
US Patent 10799575 Flavivirus and alphavirus virus-like particles (VLPS)

Technovax, Inc.
Technovax, Inc.
Technovax, Inc.
Technovax, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
10799575
October 13, 2020
‌
US Patent 8778353 Influenza virus-like particle (VLP) compositions

Patent 8778353 was granted and assigned to Technovax, Inc. on July, 2014 by the United States Patent and Trademark Office.

Technovax, Inc.
Technovax, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
8778353
July 15, 2014
‌
US Patent 9101578 Polyvalent influenza virus-like particle (VLP) compositions

Patent 9101578 was granted and assigned to Technovax, Inc. on August, 2015 by the United States Patent and Trademark Office.

Technovax, Inc.
Technovax, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
9101578
August 11, 2015
10 results
0 selected
10 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us